Osborne Partners Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Osborne Partners Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,489	Closed	-$324K	–	222
2021 Q4	$324K	Sell	3,489 -5,660	-62%	-$373K	0.02%	182
2021 Q3	$545K	Hold	9,149	–	–	0.04%	141
2021 Q2	$624K	Buy	+9,149	New	+$596K	0.05%	136

Osborne Partners Capital Management's ARNA Position: Q1 2022 in Review

Osborne Partners Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,489 shares — an estimated $324K sold.

Osborne Partners Capital Management first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $624K in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Osborne Partners Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Osborne Partners Capital Management sold 3,489 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $324K.
Osborne Partners Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Osborne Partners Capital Management's Arena Pharmaceuticals Inc position peaked at $624K in Q2 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Osborne Partners Capital Management's 13F filing for Q1 2022, filed 5 May 2022.